Table 1.
Prevalence of HCV, development parameters, and genotype distribution in North African countries.
| Maghreb region | Nile region | ||||||
|---|---|---|---|---|---|---|---|
| Countries | Libya | Tunis | Algeria | Morocco | Mauritania | Egypt | Sudan |
| Population (millions) | 6.42 | 11 | 35 | 32 | 3.5 | 82.5 | 44.6 |
| Population density (people/km2) |
04 |
71 |
16 |
76 |
04 |
90 |
22 |
| Literacy rate (M; F) | 99.95% (99.97; 99.93) | 98.06% (98.35; 97.76) | 95.59% (95.65; 95.52) |
83.19% (90.10; 75.87) |
62.63% (70.04; 54.98) | 91.12% (93.42; 88.73) |
89.57% (91.29; 87.81) |
| GNI (PPP US$) | 16020 | 3720 | 4420 | 2770 | 2400 | 6120 | 2120 |
| HDI (2010–2014) | 0.849 | 0.712 | 0.736 | 0.628 | 0.453 | 0.644 | 0.408 |
| Country classification | HI | LMI | LMI | LMI | LI | LMI | LI |
|
| |||||||
| Prevalence of HCV genotypes & subtypes | |||||||
| 1 | 35% | 67% | 89% | 68% | ? | 5% | 5% |
| 1a | 1a | 1a | 1a | 1a | — | — | |
| 1b | 1b | 1b | 1b | 1b | — | — | |
| 2 | 14.2 | 13% | 9% | 30% | ? | 2% | 3% |
| 2a | 2a | 2a | 2a, 2b | 2i, 2k | — | — | |
| 3 | 15% | 3% | 1% | — | ? | — | — |
| 4 | 29.2% | 21% | 1% | — | ? | 80% | 90% |
| 4a | 4a | 4a | 4a | — | 4a | 4a | |
| 4k | 4k | 4k | 4c, 4d | — | ? | 4k | — |
| — | |||||||
| 5 | 0.2% | — | — | — | ? | — | — |
GNI, gross national income. PPP, purchasing power parity. HDI, human development index. HI, high income. LMI, lower middle income. LI, low income.